Investor · New York, NY

Leath Bing

Open Leath in the network graph →

Filings

10

SEC Form D

Connections

33

co-filers

Capital

$10.3M

across filings

Active

Jan 2017

to Mar 2020

Most-connected co-filers (33)

Peter Mullen · New York, NY7 shared Donald R. Mclamb, Jr · Wilmington, DE6 shared Luke J. Atwood · Richmond, VA6 shared Matthew C. Harris · New York, NY4 shared Charles Berg · New York, NY4 shared Christine K. Funk · Sisters, OR4 shared Andrew F. St Pierre · Burlington, MA4 shared Glenn R. Hanson · Wilbraham, MA4 shared Sponsor Colony Hills Capital, LLC · Wilbraham, MA4 shared Amrit Shahzad · Beverly, MA4 shared Clair C. Holley · Calgary, Alberta, Canada4 shared Robert P. Flach · Ruislip, United Kingdom3 shared Neal C. Walker · Malvern, PA3 shared Randall Jacobs · INDIANAPOLIS, IN3 shared Stephen Tullman · Malvern, PA3 shared JGM Capital Management, LP · New York, NY3 shared Christopher R. Suan · New York, NY2 shared Guilherme M. Ache · RIO DE JANEIRO, Guernsey2 shared Jeff E. Margolis · Glen Rock, NJ2 shared Austin Shelton · San Francisco, CA2 shared Duff Hearon · San Francisco, CA2 shared Christopher Harrison · San Francisco, CA2 shared Arnold S. Lippa · Glen Rock, NJ2 shared Richard E. Purcell · Glen Rock, NJ2 shared

Recent filings (10)

Hexproof Inc.Feb 2026 · 1 co-filer JGM Capital Partners, LLCMar 2020 · 7 co-filers JGM Capital Partners, LLCMar 2019 · 7 co-filers RespireRx Pharmaceuticals Inc.Sep 2018 · 11 co-filers$1.5M JGM Capital Partners, LLCMar 2018 · 7 co-filers RespireRx Pharmaceuticals Inc.Sep 2017 · 11 co-filers$1.1M Archetype Alpha I Fund LPMar 2017 · 11 co-filers RespireRx Pharmaceuticals Inc.Mar 2017 · 17 co-filers$1.5M Archetype Alpha I Offshore Fund Ltd.Mar 2017 · 11 co-filers RespireRx Pharmaceuticals Inc.Jan 2017 · 19 co-filers$3.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Leath in the interactive graph →